INHALED DRY POWDER BUDESONIDE
Covid 19 treatment
No longer recommended for Covid treatment outside of a trial in line with CAS 103185
Date of classification
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.